Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 9/20 | 0.42 |
| ▸ | FNTA | P49354 | 3/20 | 0.39 |
| ▸ | FNTB | P49356 | 3/20 | 0.39 |
| ▸ | PGGT1B | P53609 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7090215 | 0.79 | FNTA (0.48) | RORCFNTAFNTBPGGT1B | |
| SCHEMBL7191222 | 0.78 | FNTA (0.45) | RORCFNTAFNTB | |
| SCHEMBL6009561 | 0.76 | FNTA (0.49) | FNTAFNTBPGGT1B | |
| SCHEMBL7093092 | 0.75 | FNTA (0.44) | RORCFNTAFNTBPGGT1B | |
| SCHEMBL7095411 | 0.74 | FNTA (0.41) | RORCFNTAFNTBPGGT1B | |
| SCHEMBL7168166 | 0.73 | RORC (0.38) | RORCFNTAFNTB | |
| SCHEMBL5016765 | 0.73 | FNTA (0.46) | FNTAFNTBPGGT1B | |
| SCHEMBL16632803 | 0.70 | RORC (0.59) | RORC | |
| SCHEMBL7643836 | 0.70 | FNTA (0.47) | RORCFNTAFNTBPGGT1B | |
| SCHEMBL7195141 | 0.70 | FNTA (0.47) | RORCFNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1322636-A1 | FARNESYL TRANSFERASE INHIBITING 6- (SUBSTITUTED PHENYL)METHYL]-QUINOLINE AND QUINAZOLINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002024683-A1 | FARNESYL TRANSFERASE INHIBITING 6-[(SUBSTITUTED PHENYL)METHYL]-QUINOLINE AND QUINAZOLINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-03-28 | — | — | WO | disclosed |